Brain Tumor Awareness

Wen reports receiving research support from Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Chimerix, Eli Lily, Erasca, Global Coalition For Adaptive Research, Kazia, MediciNova, Merck, Novartis, Quadriga, Servier, VBI Vaccines, and serving on advisory boards or as a consultant for Anheart, Astra Zeneca, Black Diamond, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Kintara, Merck, Mundipharma, Novartis, Novocure, Prelude Therapeutics, Sagimet, Sapience, Servier, Symbio, Tango, Telix and VBI Vaccines.

May 26, 2023

1 min watch

Save

VIDEO: Earlier palliative care, more support emphasized in brain cancer care

Transcript

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Few things in life are more devastating than having a brain tumor, both to the patient and to the patient's family. And so there's been a growing emphasis on providing these patients with more support with earlier palliative care, and also providing the families with more support. In particular, there are now trials going on to look at interventions both for the patient and their caregivers — trials to introduce earlier palliative care, to introduce strategies to help with the stress of dealing with these diagnoses. And there are also trials looking at interventions for caregivers to help them cope better and to provide better support for their loved ones. So, this is an area that that's starting to develop in a very positive way, although there's still a long way to go to help the patients more.